Optimizing Clinical Evaluation of the Infertile Male: Current Guidelines, Gaps, and Future Directions

Abstract

Male infertility contributes substantially to the global burden of infertility and is implicated in approximately half of infertile partnerships. Contemporary evaluation has expanded beyond conventional semen analysis to include endocrine, genetic, and targeted imaging assessments, reflecting a broader understanding of male reproductive dysfunction as both a fertility disorder and a potential marker of systemic disease. Still unable to identify specific diagnostic gaps, and make an overview of future directions which are likely to provide advances in precision diagnostics and clinical decision-making. Objective: To summarize and discuss contemporary recommendations among the American Urological Association and American Society for Reproductive Medicine, the European Association of Urology and the World Health Organization jointly, as well as the latest peer-reviewed research on epidemiology, genetics, sperm DNA integrity and advanced diagnostics as related to male infertility. Modem recommendations advocate an evaluated approach that includes thorough reproductive history, medical history and physical examination, a minimum of one well-executed semen analysis, directed endocrine assessment, judicious genetic investigation and imaging in narrowly defined clinical contexts. There are still large diagnostic gaps, particularly for men classified as either idiopathic infertility or severe spermatogenic failure. The present approaches for assessment are clinically valid but not comprehensive. Integration of validated molecular diagnostics, broader genomic testing in selected patients, and outcome-focused research may improve diagnostic yield and support more individualized management strategies.